OHRP Ohr Pharmaceuticals, Inc.

0.65
+0.02  (4%)
Previous Close 0.63
Open 0.63
Price To book 1.21
Market Cap 36.54M
Shares 56,211,000
Volume 224,526
Short Ratio 6.60
Av. Daily Volume 347,828

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 data due late 2017 or early 2018.
OHR-102 (MAKO)
Neovascular (Wet) Age-related Macular Degeneration (AMD)
Phase 2 data released July 2015
OHR-102
Retinal vein occlusion (CRVO)

SEC Filings

  1. 8-K - Current report 17839078
  2. 10-Q - Quarterly report [Sections 13 or 15(d)] 17835521
  3. 8-K - Current report 17834445
  4. NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB 17828598
  5. 8-K - Current report 17770487
  6. 8-K - Current report 17754264
  7. 8-K - Current report 17746096
  8. 424B5 - Prospectus [Rule 424(b)(5)] 17746066
  9. 424B5 - Prospectus [Rule 424(b)(5)] 17739571
  10. 8-K - Current report 17738886